Join us for an interactive hTEE discussion with renowned luminaries in critical care medicine.
To attend the event,
please contact us at press@imacorinc.com.
|
|
Featured Conferences
14th Capital City Conference of the DGAI:
September 13 - 15, 2012 |
SOCCA Annual Meeting Washington, DC, USA October 11 - 12, 2012 |
Testimonial
"This device has proven to be an invaluable new adjunct in the SCCU by allowing previously unobtainable continuous real time monitoring of the MCS/H-Txp patient. Use of the ImaCor TEE-probe provides the cardiac intensivist with timely important clinical data that improves patient care and is economically advantageous."
Harrison Pitcher MD et al.
[Thomas Jefferson University Hospital] in abstract titled, "Application of the Miniaturized ImaCor Trans-Esophageal Echocardiogram (TEE) Probe in Heart Transplant/Mechanical Cardiac Support Patients." Presented at the 32nd Annual Meeting of the International Society of Heart & Lung Transplantation (ISHLT) in Prague, April 2012.
|
|
Tobias Merz MD imaging with a next generation Zura EVO at Bern University Hospital in Switzerland.
|
|
 | |
Fred Rincon MD in the NEURO ICU at Thomas Jefferson University Hospital utilizing a probe. Tia Boylan, RDCS of ImaCor on right.
|
|
Should you wish to submit an article to our next monthly newsletter, please contact
Sheila McGarrigle
at newsletter@imacorinc.com
|
|
|
|
 
hTEE Management of a Severely Burned Patient
Donald Reiff MD and S. Chris Bellot MD
University of Alabama at Birmingham, Birmingham, AL, USA
(To Read the Full Case Report, click here)
 | Donald Reiff MD
|
This case report describes how hTEE™, hemodynamic management guided by a miniaturized, disposable transesophageal ultrasound probe (ClariTEEŽ, ImaCor Inc., Garden City, NY) was used in the management of an immuno-suppressed patient with AIDS, 65% BSA burned, and presumed sepsis. hTEE was ordered in this setting three days post-admission, and notably following resuscitation with a modified Brooke formula. hTEE revealed an underfilled LV, hypovolemia not detected by PAC (diastolic pressure 17 mmHg).
Read More Share:     |
hTEE-guided Management of a Patient with a Cardiac History and Presumed Sepsis: Pressor Weaning and Aggressive Fluid Resuscitation
Larisa Zhurav MD
Barnes-Jewish Hospital, St.Louis, MO, USA
(To Read Full Case Report, click here)
A 68-year-old male with a cardiac history presented with elevated troponins and abnormal ECG one day status post abdominal surgery, with BP maintained by norepinephrine and a diagnosis of presumed sepsis. The differential diagnosis and subsequent treatment can be challenging in such cases - cardiac output depends upon preload (volume), contractility and afterload, and typical sepsis protocols call for both fluids and pressors. TEE has long been recognized as the gold standard in assessing cardiac filling and function, but can frequently be impractical to use as a management tool over the course of resuscitation. This case illustrates the use of a miniaturized hemodynamic transesophageal echocardiography probe (ClariTEEŽ, ImaCor, Inc., NG tube-sized) to perform hemodynamic TEE (hTEE™) assessment and management over a period of 29 hours. hTEE management led to aggressive fluid resuscitation and weaning from pressors, resulting in near normal cardiac filling and function. |
Click on the image for more information.
The ImaCor Reading Room is a value-added, online training tool designed to introduce clinicians with limited echo experience to the 3 basic hTEE views, and to discern normal from abnormal anatomy.
Share:
Back to Top
|
The Soul of Our New Machine:
the Zura EVO
by Harold Hastings PhD, Co-Founder and Chief Technology Officer, ImaCor Inc.
(To Read Full Article, click here)
 With the first US and European installs of ImaCor's new Zura EVO,
I am using this column to briefly reflect on its evolution. On one level, the Zura EVO consists of ultrasound and computer hardware, computer software, a user interface, a stand, etc. But on a deeper level, the Zura EVO is intended to reflect what our customers need to better treat their patients. On this level, the Zura EVO consists of the knowledge, passion, and hard work of a large team, including you, the users and readers. . . . how your past, present and future commitment to patient care led us to develop the Zura EVO. . . |
Top Economic Reads This Summer
 Looking for some brief summer reads? Try some of these favorites recommended by our Quality Assurance and Regulatory Affairs Director, Rich Lanzillotto:
- Kramer, Zimmerman et al. Economics - A predictive model for the early identification of patients at risk for a prolonged intensive care unit length of stay. BMC Medical Informatics and Decision Making. 2010, 10:27 http://www.biomedcentral.com/1472-6947/10/27
- Zenati, Billiar et al. Trauma - A brief episode of hypotension increases mortality in critically ill trauma patients J Trauma. 2002;53:232-237.
- Levy, Macias et al Sepsis - Early changes in organ function predict eventual survival in severe sepsis Crit Care Med. 2005 33:2194-2201.
Combined, these studies provide a clear picture of how, by utilizing a medical management tool early on to address the patient's hemodynamic instability, hospitals can better manage their ICU length of stays (LOS). The hTEE probe allows the physician to manage the patient's hemodynamic therapy, providing a better outcome for the patient and reducing LOS in the ICU. Happy Summer Reading!
Share:
Back to Top
|
ImaCor congratulates NYU Langone Medical Center and The Medical Center of Central Georgia (MCCG) for their recent purchase and installation of hTEE Zura Imaging Systems.
We recognize NYU Langone and MCCG as leading hospitals, promoting and investing in best practices for excellence in patient care and safety.
Share:
Back to Top
|
|
Summer is often a time of retreat, but here at ImaCor it is one of advance. We are driven by the key issues facing critical care teams. Our clinical specialists are working around the clock training new fellows and attendings at our sites. Our sales and marketing teams are presenting at forums around the world - India, Finland, Germany - in addition to an ever-growing list of sites here in the States. And our engineers - who only last month released the next generation Zura ultrasound platform, the EVO - are developing and refining an arsenal of technologies that will continue to uniquely address fundamental concerns in critical care provision.
Our focus also remains razor-sharp on supporting our physician users through partnerships with their hospital administrations to formally recognize hTEE's role in improving patient care and reducing costs. ImaCor's cost justification model, our hTEE New Technology Assessment (NTA), is gaining momentum at our sites as a best practice in sharing the risk, and modeling the rewards, of new technology. Our clinical specialists are integral to each hospital's NTA success, through tirelessly educating on the value and application of hTEE as well as then collecting data for hospital administrators to assess the resulting financial impact. To that end, we are expanding our team of clinical specialists in the United States and Europe, and trust that our customer sites will appreciate the continuing education and exceptional support they receive from these talented individuals.
And so, as the lazy days of summer surround us, know that we are here welcoming your feedback, strategizing best ways to image and optimize cardiac performance in your most hemodynamically unstable patients, and ever advancing our research and technology developments for perioperative and critical care.
With warm wishes for a safe and healthy summer,
Peter Pellerito
President & CEO
|
|
|
